Mark Landy
Mark Landy
appreciation avoid firm higher offer promises stock takes
This offer is superior. This offer promises a higher price, stock with better appreciation potential, commitments to do what it takes to avoid antitrust concerns, and a firm timeline.
litigation lower negotiate open problem themselves
If they do negotiate a lower price, they may open themselves up to litigation by essentially conceding that there has been a problem under management's watch.
outside venture
I would venture that we are now outside of gentlemanly territory,
believe boston deals scientific
If the deals went to shareholders today, we believe Boston Scientific would prevail.
boston downside material next scientific upside
I don't see material upside or downside (for Boston Scientific shares) for the next 12 months.
clear doctors johnson price products reward risk run setting technology
While Johnson & Johnson has the clear technology lead, the risk they run is in setting the price. If the price is favorable, doctors will reward them when new products come to market.
expected folks
I think a lot of folks had not expected them to be back this quickly.
difficult large operating
We are operating in a large vacuum. It's exceedingly difficult to speculate.
clean found sends ship somebody
It they found somebody who could clean up ship a little, it sends a message.
boston continue expect helps hurts leverage prices recognizes scientific
We expect prices to continue to decline. Leverage helps on the way up and it hurts on the day down. Boston Scientific recognizes it and that's why they want Guidant.
buying crown jewel reasonable
They are buying a crown jewel and they are getting it at a reasonable valuation.
constantly sit
You can't just sit back on your laurels. You have to constantly innovate.
simple
This is a very simple integration. It should not be difficult.
deal price proceed sure
The deal will proceed if J&J will get the price it wants. I am not sure Guidant will give them that price.